Advancing Microfluidics and Biomimetic Materials for Miniaturized Cell Screening Platforms: Unleashing Insights into Complex Disease Mechanisms and Personalized Medicine

Recent developments in the field of microfluidics and fabrication of novel biomimetic materials have enabled scientists worldwide to design miniaturized cell screening platforms with a wide range of experimental applications. These miniaturized lab-on-a-chip systems provide a controlled and scalable cellular microenvironment for a large number of biological samples under different conditions. In the context of complex disease analysis, these microfabricated platforms serve as powerful tools for understanding disease mechanisms and discovering novel therapeutics through high-throughput screening of drugs and other small molecules with cells grown in miniaturized assay volumes. The integration of different experimental techniques, such as live cell monitoring, drug screening, and analysis of phenotypic and molecular outcomes, demonstrates the potential of these alternative platforms as the ultimate “sample-in-answer-out” systems. Microfluidic techniques have played a critical role in the development of portable and rapid point-of-care diagnostic devices, particularly in emergency setups. Moreover, microfluidic technologies have revolutionized the field of tissue engineering by creating sophisticated platforms that allow the formation of spheroids, human tissues, and even miniature organs on a chip, accelerating the development of personalized medicine and targeted therapeutic strategies. With the ability to recreate disease-specific microenvironments, enable real-time monitoring of cells, and integrate multiple experimental techniques with different readouts into a single device, these miniaturized platforms offer unprecedented insights into complex disease mechanisms.